What is Vapi?
Vapi is a modern platform that enables developers to rapidly build and deploy sophisticated voice AI agents. It provides everything needed to create conversational voice AI capable of natural dialogue, solving real business problems, and operating at enterprise scale.
Core Features
The platform offers a unified environment for all voice agents. Users can configure voice, conversation flow, telephony, and integrations. Vapi manages the entire infrastructure, allowing teams to go from prompt to production in minutes. Built-in orchestration, real-time monitoring, and analytics help continuously improve customer experiences.
Supported use cases include Customer Support, Lead Qualification, and Appointment Scheduling. Companies report routing 100% of inbound volume through Vapi agents while maintaining or improving CSAT scores.
Enterprise Readiness
Vapi is built for large organizations. It provides SLA guarantees, dedicated engineering support, SSO, OAuth, RBAC, AI Guardrails to prevent hallucinations, and compliance with SOC 2, HIPAA, and PCI standards. The infrastructure scales to millions of calls with sub-500ms latency.
Real-World Usage
The service is trusted by major companies in Latin America and the US. One client achieved profitability in new markets and doubled customer capacity while significantly improving service quality through Vapi voice agents. The platform supports multiple languages including English, Spanish, Italian, and French.
Thanks to its API-first design, developers can deeply integrate Vapi into existing systems. It is particularly effective for automating call centers, outbound sales, and inbound support.
Pros and Cons
- Pros: extremely fast development, enterprise-grade security and compliance, excellent scalability, proven improvement in customer experience and business metrics.
- Cons: core advanced functionality requires a paid plan, optimal results require expertise in prompt engineering and conversation design.
Vapi stands as one of the most powerful voice AI platforms available in 2025.